This translocation creates a novel fusion gene, BCR-ABL, which encodes a constitutively active isoform of ABL tyrosine kinase (TK) and leads to pathophysiology of CML [2–5]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.